Literature DB >> 12709778

Comparison of the effects of antipsychotics on a delayed radial maze task in the rat.

Mary C Wolff1, J David Leander.   

Abstract

RATIONALE: The cognitive impairments evident in many schizophrenics are related to the severity of their negative symptoms and ability to function in society. Drugs that alleviate cognitive impairments, in addition to other psychotic symptoms, may have an important influence on treatment outcome and the course of the illness.
OBJECTIVES: A delayed non-match to sample task conducted in an eight-arm radial maze was used to determine the influence of four atypical antipsychotics (olanzapine, ziprasidone, risperidone, and clozapine), as well as a typical neuroleptic (haloperidol) on consolidation processes in healthy rats.
METHOD: Well-trained rats were required to recall after a 7-h delay where they had received food pellets during an information phase (first four arm choices) in order to obtain the remaining food pellets during a retention phase (second four arm choices).
RESULTS: The total number of errors that occurred during the retention session increased with increasing delay periods from 0 to 7 h. When administered orally immediately after the information phase, olanzapine (3 and 5 mg/kg) and risperidone (0.1 mg/kg) significantly reduced the number of errors made during the retention phase. Under the same conditions, clozapine, ziprasidone and haloperidol failed to affect the total number of retention phase errors.
CONCLUSION: Some atypical antipsychotics, such as olanzapine and risperidone, improve consolidation processes and may alleviate the cognitive impairments associated with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709778     DOI: 10.1007/s00213-003-1449-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

Review 1.  Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia.

Authors:  H E Spohn; M E Strauss
Journal:  J Abnorm Psychol       Date:  1989-11

2.  Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine.

Authors:  F P Bymaster; J F Falcone; D Bauzon; J S Kennedy; K Schenck; N W DeLapp; M L Cohen
Journal:  Eur J Pharmacol       Date:  2001-11-02       Impact factor: 4.432

3.  Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats.

Authors:  Manickam Aravagiri; Stephen R Marder
Journal:  Psychopharmacology (Berl)       Date:  2001-11-20       Impact factor: 4.530

4.  Memory persistence of rats in a radial maze varies with training procedure.

Authors:  A M Strijkstra; J J Bolhuis
Journal:  Behav Neural Biol       Date:  1987-03

5.  Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile.

Authors:  A W Schmidt; L A Lebel; H R Howard; S H Zorn
Journal:  Eur J Pharmacol       Date:  2001-08-17       Impact factor: 4.432

6.  Effects of D-cycloserine, a positive modulator of N-methyl-D-aspartate receptors, and ST 587, a putative alpha-1 adrenergic agonist, individually and in combination, on the non-delayed and delayed foraging behaviour of rats assessed in the radial arm maze.

Authors:  R Pussinen; J Sirviö
Journal:  J Psychopharmacol       Date:  1999       Impact factor: 4.153

7.  Facilitation of glutamate receptors enhances memory.

Authors:  U Staubli; G Rogers; G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

8.  Differential effect of antipsychotics on place navigation of rats in the Morris water maze. A comparative study between novel and reference antipsychotics.

Authors:  T Skarsfeldt
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

9.  Spatial working memory in rats: effects of monoaminergic antagonists.

Authors:  W W Beatty; J R Rush
Journal:  Pharmacol Biochem Behav       Date:  1983-01       Impact factor: 3.533

10.  An attempt to account for controversial estimates of working memory persistence in the radial maze.

Authors:  A Markowska; O Buresová; J Bures
Journal:  Behav Neural Biol       Date:  1983-05
View more
  10 in total

Review 1.  Regional differences in the action of antipsychotic drugs: implications for cognitive effects in schizophrenic patients.

Authors:  Richard J Beninger; Tyson W Baker; Matthew M Florczynski; Tomek J Banasikowski
Journal:  Neurotox Res       Date:  2010-04-08       Impact factor: 3.911

2.  Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in mice.

Authors:  Stephanie J Klenotich; Mariel P Seiglie; Matthew S McMurray; Jamie D Roitman; Daniel Le Grange; Priya Dugad; Stephanie C Dulawa
Journal:  Neuropsychopharmacology       Date:  2012-03-07       Impact factor: 7.853

Review 3.  Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder.

Authors:  Tracy Swainston Harrison; Lesley J Scott
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 4.  Pharmacological enhancement of memory and executive functioning in laboratory animals.

Authors:  Stan B Floresco; James D Jentsch
Journal:  Neuropsychopharmacology       Date:  2010-09-15       Impact factor: 7.853

5.  Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol.

Authors:  Taku Nagai; Kazuhiro Takuma; Misato Dohniwa; Daisuke Ibi; Hiroyuki Mizoguchi; Hiroyuki Kamei; Toshitaka Nabeshima; Kiyofumi Yamada
Journal:  Psychopharmacology (Berl)       Date:  2007-05-20       Impact factor: 4.530

6.  Risperidone and ritanserin but not haloperidol block effect of dizocilpine on the active allothetic place avoidance task.

Authors:  Vera Bubenikova-Valesova; Ales Stuchlik; Jan Svoboda; Jan Bures; Karel Vales
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-14       Impact factor: 11.205

7.  Olanzapine attenuates postoperative cognitive dysfunction in adult rats.

Authors:  Keitaro Tachi; Taeko Fukuda; Makoto Tanaka
Journal:  Heliyon       Date:  2021-02-12

8.  Asenapine effects in animal models of psychosis and cognitive function.

Authors:  Hugh M Marston; Jared W Young; Frederic D C Martin; Kevin A Serpa; Christopher L Moore; Erik H F Wong; Lisa Gold; Leonard T Meltzer; Marc R Azar; Mark A Geyer; Mohammed Shahid
Journal:  Psychopharmacology (Berl)       Date:  2009-05-22       Impact factor: 4.530

Review 9.  Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective.

Authors:  Madeleine Monique Uys; Mohammed Shahid; Brian Herbert Harvey
Journal:  Front Psychiatry       Date:  2017-08-14       Impact factor: 4.157

10.  Pro-cognitive effect of 1MeTIQ on recognition memory in the ketamine model of schizophrenia in rats: the behavioural and neurochemical effects.

Authors:  Magdalena Białoń; Marcelina Żarnowska; Lucyna Antkiewicz-Michaluk; Agnieszka Wąsik
Journal:  Psychopharmacology (Berl)       Date:  2020-02-20       Impact factor: 4.415

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.